Jammu: Divisional Commissioner, Jammu, Dr Raghav Langer today reviewed the stock and supply position of essential drugs for the treatment of Covid positive patients, here at a meeting at the Drug Controller Office, Jammu.
The meeting was attended by Deputy Commissioner Jammu, Anshul Garg; MD National Health Mission, Yasin Choudhary; UT Drugs Controller J&K, Lotika Khajuria, MD JKMSCL Dr Yashpal Sharma besides Assistant Drugs Controllers, DCOs and other concerned officers.
UT Drugs Controller apprised the Div Com that the Drug Controller General of India has designated Remdesivir as a institutional supply only drug in view of the emerging Covid situation and a quota of 10,500 vials per week has been fixed for J&K by GoI, at present.
The rates have also been freezed by the National Pharmaceutical Pricing Authority (NPPA).
The Drug Controller informed that they have prepared list of drugs used for the treatment of the Covid positive patients and the same is being regulated. She informed that adequate stock of essential drugs is available and the supply to various government health care institutions and dedicated Covid Hospitals across Jammu division was being maintained.
The Div Com directed all Drug Control Officers to ensure strict market enforcement & surveillance and stringent possible action under the provisions of Drugs & Cosmetics Act, Drugs Control Order and Disaster Management Act be taken in case of any instance of hoarding, black marketing by the unscrupulous elements so that the injection reach to the genuine patients in the Government hospitals and designated private Covid hospitals.
Instructions were also issued to the Drug Controller to submit daily log of sale purchase to the office of divisional commissioner. DC Jammu was directed to constitute market checking teams to curb any malpractice at this juncture. Lawful action was directed to be taken against concerned manufacturers/stockists who are not providing the designated quota to JKMSCL for hospital supplies.
He instructed the Drug Controller to appoint a nodal officer, who will be deputed outside the UT to coordinate with the manufactures and ensure regular supply of the allocated quota.
The Drug Controllers was further directed to maintain adequate supplies for use of Armed forces/CAPF’s. Similar instructions were issued to ensure supplies and check any diversion of Toclizumab & other drugs.